Analyst InsightsBiotech Stocks These 3 Biotech Stocks Could More Than Double in 2020, Says Wedbush Which stocks can go from zero to one hundred overnight? Wall Street pros point to biotechs. Maya Sasson, November 29, 2019
Analyst InsightsBiotech Stocks Don’t Say Bye Bye to Intercept (ICPT) Stock, Say Buy Buy With Intercept (ICPT) preparing to release Phase 3 results from its REGENERATE study in Non-Alcoholic Steatohepatitis (NASH) patients, Gilead (GILD) announced yesterday that its top late-stage NASH drug … Jason Cohen, February 12, 2019
Biotech StocksStock News Company Update (NASDAQ:ICPT): Intercept Pharmaceuticals Inc Announces 3Q:17 Financial Results and Provides Business Update Intercept Pharmaceuticals Inc (NASDAQ:ICPT) reported financial results for the three months ended September 30, 2017, and provided other general business updates. “We are … Corey Williams, November 1, 2017
Biotech StocksStock News Intercept Pharmaceuticals Inc (ICPT) Presents Additional Results From Phase 2 Study of OCA for the Treatment of Patients with PSC Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced additional results of the phase 2 clinical trial with obeticholic acid (OCA), a potent farnesoid X receptor agonist … Corey Williams, October 23, 2017
Bloggers CornerExclusiveHealthcareTop Stories Marshall Wace Pulled Back Holding in Intercept Pharmaceuticals Inc (ICPT), Optimistic About Valeant Pharmaceuticals Intl Inc (VRX) and Exelixis, Inc. (EXEL) A first glance at this hedge fund’s strategic Q2 moves in biotech sector. Zach Wohlberg, September 25, 2017
Biotech StocksStock News A Glimpse Into the Biotech Sector: Intercept Pharmaceuticals Inc (ICPT), IntelliPharmaCeutics Intl Inc (USA) (IPCI) Intercept Pharmaceuticals Inc (NASDAQ:ICPT) management hosted a conference call this morning to address Ocaliva safety concerns. As a reminder, company issued a Healthcare … Smarter Team, September 25, 2017
Biotech StocksStock News Intercept Pharmaceuticals Inc (ICPT) Comments on Ocaliva Safety and Dosing Intercept Pharmaceuticals Inc (NASDAQ:ICPT) provided comment on the Ocaliva (obeticholic acid or OCA) Dear Healthcare Provider (DHCP) letter issued on September 12, 2017, … Corey Williams, September 25, 2017
Biotech StocksTop-Rated Analysts Top Analyst Cuts Price Target For Intercept Pharmaceuticals Inc (ICPT) By 50%; Here’s Why Intercept Sank 40% in September following Dear Doctor and FDA warning letters; Ritu Baral weighs in. Jason Cohen, September 22, 2017
Biotech StocksMost PopularStock News Intercept Pharmaceuticals Inc (ICPT) Investors Run for the Hills; Here’s Why Shares of drug maker Intercept Pharmaceuticals Inc (NASDAQ:ICPT) are in a freefall today. Why? Corey Williams, September 21, 2017
Biotech StocksTop-Rated Analysts Top Analyst Shines Light on Intercept Pharmaceuticals Inc’s (ICPT) Dear Health Care Provider Letter Dear doctor: My shares just fell 15%. Jason Cohen, September 12, 2017
